Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,816,426
+$4,434,587 QoQ
Shares Held
14,868
+65.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Crawford Fund Management, LLC holds $15,632,183 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (56.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
14,868 | $8,816,426 | |
| 2 | HROW |
Harrow, Inc.
|
193,300 | $6,815,757 |
All Filings in UTHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,816,426 | 14,868 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,381,839 | 8,993 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,600,092 | 20,515 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,636,260 | 37,015 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,728,664 | 28,315 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,649,570 | 21,680 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,490,027 | 23,692 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,703,279 | 33,600 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,718,591 | 33,600 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,904,545 | 31,400 | Shares | Other | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||